SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001437749-23-024952
Filing Date
2023-08-31
Accepted
2023-08-31 16:15:35
Documents
13
Period of Report
2023-07-17
Items
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A pirs20230823c_8ka.htm   iXBRL 8-K/A 30156
  Complete submission text file 0001437749-23-024952.txt   169024

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA pirs-20230717.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pirs-20230717_def.xml EX-101.DEF 12175
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE pirs-20230717_lab.xml EX-101.LAB 16369
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pirs-20230717_pre.xml EX-101.PRE 12445
7 EXTRACTED XBRL INSTANCE DOCUMENT pirs20230823c_8ka_htm.xml XML 2795
Mailing Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110
Business Address 225 FRANKLIN STREET 26TH FLOOR BOSTON MA 02110 857-246-8998
PIERIS PHARMACEUTICALS, INC. (Filer) CIK: 0001583648 (see all company filings)

IRS No.: 300784346 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-37471 | Film No.: 231229220
SIC: 2834 Pharmaceutical Preparations